Sign for Notice Everyday    Sign Up| Sign In| Link| English|

Our Sponsors

    Receive Latest News

    Feedburner
    Share Us


    Biology and Pathology of Infectious Disease Conference

    View: 369

    Website https://biopathology.pathologyconferences.com/ | Want to Edit it Edit Freely

    Category Pathology; diagnosis; Infectious disease

    Deadline: October 18, 2018 | Date: October 19, 2018-October 20, 2018

    Venue/Country: Helsinki, Finland

    Updated: 2018-03-30 20:25:08 (GMT+9)

    Call For Papers - CFP

    The International Conference on Biology and Pathology of Infections is going to be held at Helsinki, Finland during October 18-19, 2018 hosted by ME Conferences. Through the theme "World Dream of Obliterating Infection", conference will explore the advances in Pathological Infections, Pulmonary Pathology, Anti-microbial Immunization, etc. This conference could be a remarkable event that carries the mixture of novel and advanced pathological techniques for the diagnosis of emerging infectious diseases. It will provide an international platform to share expertise, foster collaborations across trade and world, and assess rising technologies across the world.

    ME Conferences Organizes 1000+ Global Events every year across Middle East, USA, Europe & Asia with support from 1000 more scientific societies which contains over 50000 reputed scientists, renowned personalities as editorial board members. The conference proceedings will be published in the related journals of the conference, which will be maintained with open access rights


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.